| Tumor mutational load predicts survival after immunotherapy across multiple cancer types RM Samstein, CH Lee, AN Shoushtari, MD Hellmann, R Shen, ... Nature genetics 51 (2), 202-206, 2019 | 3075 | 2019 |
| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 2918 | 2017 |
| IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype S Turcan, D Rohle, A Goenka, LA Walsh, F Fang, E Yilmaz, C Campos, ... Nature 483 (7390), 479-483, 2012 | 2108 | 2012 |
| Tumor and microenvironment evolution during immunotherapy with nivolumab N Riaz, JJ Havel, V Makarov, A Desrichard, WJ Urba, JS Sims, FS Hodi, ... Cell 171 (4), 934-949. e16, 2017 | 1711 | 2017 |
| Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy D Chowell, LGT Morris, CM Grigg, JK Weber, RM Samstein, V Makarov, ... Science 359 (6375), 582-587, 2018 | 996 | 2018 |
| The head and neck cancer immune landscape and its immunotherapeutic implications R Mandal, Y Şenbabaoğlu, A Desrichard, JJ Havel, MG Dalin, N Riaz, ... JCI insight 1 (17), 2016 | 677 | 2016 |
| Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic B Givi, BA Schiff, SB Chinn, D Clayburgh, NG Iyer, S Jalisi, MG Moore, ... JAMA otolaryngology–head & neck surgery 146 (6), 579-584, 2020 | 628 | 2020 |
| The increasing incidence of thyroid cancer: the influence of access to care LGT Morris, AG Sikora, TD Tosteson, L Davies Thyroid 23 (7), 885-891, 2013 | 610 | 2013 |
| The mutational landscape of adenoid cystic carcinoma AS Ho, K Kannan, DM Roy, LGT Morris, I Ganly, N Katabi, D Ramaswami, ... Nature genetics 45 (7), 791-798, 2013 | 470 | 2013 |
| Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance RM Tuttle, JA Fagin, G Minkowitz, RJ Wong, B Roman, S Patel, B Untch, ... JAMA Otolaryngology–Head & Neck Surgery 143 (10), 1015-1020, 2017 | 443 | 2017 |
| Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response R Mandal, RM Samstein, KW Lee, JJ Havel, H Wang, C Krishna, ... Science 364 (6439), 485-491, 2019 | 439 | 2019 |
| Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation LGT Morris, AM Kaufman, Y Gong, D Ramaswami, LA Walsh, Ş Turcan, ... Nature genetics 45 (3), 253-261, 2013 | 432 | 2013 |
| Characterization of HPV and host genome interactions in primary head and neck cancers M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ... Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014 | 415 | 2014 |
| Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus–associated oropharyngeal cancer LGT Morris, AG Sikora, SG Patel, RB Hayes, I Ganly Journal of clinical oncology 29 (6), 739, 2011 | 398 | 2011 |
| Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors via the hippo pathway Z Li, P Razavi, Q Li, W Toy, B Liu, C Ping, W Hsieh, F Sanchez-Vega, ... Cancer cell 34 (6), 893-905. e8, 2018 | 364 | 2018 |
| Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS) AS Ho, EE Sarti, KS Jain, H Wang, IJ Nixon, AR Shaha, JP Shah, ... Thyroid 24 (5), 832-839, 2014 | 353 | 2014 |
| Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy NG Iyer, LGT Morris, RM Tuttle, AR Shaha, I Ganly Cancer 117 (19), 4439-4446, 2011 | 347 | 2011 |
| Breast cancer methylomes establish an epigenomic foundation for metastasis F Fang, S Turcan, A Rimner, A Kaufman, D Giri, LGT Morris, R Shen, ... Science translational medicine 3 (75), 75ra25-75ra25, 2011 | 346 | 2011 |
| A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ... Movement Disorders 29 (4), 470-478, 2014 | 311 | 2014 |
| Immunogenic neoantigens derived from gene fusions stimulate T cell responses W Yang, KW Lee, RM Srivastava, F Kuo, C Krishna, D Chowell, ... Nature medicine 25 (5), 767-775, 2019 | 307 | 2019 |
